This is a large, phase III trial that aims to recruit around 4,300 patients from the UK, Hong Kong, Australia and New Zealand.
What's involved?
Patients will be randomly allocated to one of two groups:
Group 1: Treatment group. Patients will be given lidocaine during anaesthesia as well as up to 24 hours after surgery.
Group 2: Placebo group. Patients will be given placebo during anaesthesia and 24 hours after surgery.
You won't know which group will will be in.
Who is it for?
Inclusion Criteria:
Exclusion Criteria:
There are also other exclusion criteria which might mean mean you will not be able to take part in this trial. Check with your study site to see if this trial is right for you.
Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz
Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to intouch@bcf.org.nz
Subscribe for updates & stay in the loop with new studies.